ZN-7035

N/A

Report date: 2025/07/04 16:55:30
NME

Base Information

Drug NameZN-7035
Drug Alias NameZN-7035
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProbable global transcription activator SNF2L2 inhibitors
TargetsProbable global transcription activator SNF2L2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZion Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZion Pharma Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A